Walid M Heneine

This inventor holds 30 USPTO granted patents and 13 published patent applications, plus 5 CIPO patents and 6 EPO patents, primarily in HIV Research. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Johns Hopkins University, The United States of America as Represented by the Department of Health. Active years: 1998-2026.

USPTO Granted Patents = 30 (Patent Applications = 13)

% Patents Active = 60.0

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 40(Granted Patents)

Location History:

Decatur, GA (US) (1998 - 2000)
Atlanta, GA (US) (2002 - 2021)

Company Filing History:

26 out of 3,690

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4 out of 3,795

Johns Hopkins University

patents

2 out of 1,217

The United States of America as Represented by the Department of Health

patents

4. 1 out of 4

Center for Disease Control and Prevention

patents

5. 1 out of 26

Centers for Disease Control and Prevention

patents

6. 1 out of 1

Viiv Healthcare Company; and

patent

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

HIV Viral Remission

Antiretroviral Agents

Monoclonal Antibody

Real-Time PCR

Point Mutation Assays

Chemoprophylaxis

HIV Resistance

Retrovirus Detection

Xenogeneic Graft

Reverse Transcriptase

Primate T-Lymphotropic Viruses

Simian T-Cell Lymphotropic Virus

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12616692 - Method of achieving HIV viral remission using long-acting antiretroviral agents (2026-05-05),

2. 11191763 - HIV post-exposure prophylaxis (2021-12-07),

3. 11186651 - Monoclonal antibody for the detection of the antiretroviral drug emtricitabine (FTC, 2',3′-dideoxy-5-fluoro-3′-thiacytidine) (2021-11-30),

4. 10793902 - Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs (2020-10-06),

5. 10738365 - Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs (2020-08-11),

6. 10519518 - Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs (2019-12-31),

7. 10335423 - Inhibition of HIV infection through chemoprophylaxis (2019-07-02),

8. 9937191 - Inhibition of HIV infection through chemoprophylaxis (2018-04-10),

9. 9879317 - Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs (2018-01-30),

10. 9579333 - Inhibition of HIV infection through chemoprophyalxis (2017-02-28),

11. 9476103 - Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs (2016-10-25),

12. 9435000 - Primate T-lymphotropic viruses (2016-09-06),

13. 9044509 - Inhibition of HIV infection through chemoprophylaxis (2015-06-02),

14. 8663968 - Simian T-cell lymphotropic virus (2014-03-04),

15. 8592146 - Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs (2013-11-26),

Title: Walid M Heneine - Pioneering Inventor from Atlanta, GA

Introduction: Walid M Heneine is a renowned inventor based in Atlanta, GA, known for his groundbreaking contributions to the field of medical technology.

Latest Patents: Walid M Heneine holds several patents in the medical device industry, focusing on innovative solutions for improving patient care and treatment outcomes.

Career Highlights: With a career spanning over two decades, Walid M Heneine has worked tirelessly to develop cutting-edge medical technologies that have revolutionized the healthcare industry. His commitment to innovation and excellence has earned him recognition as a leading figure in the field.

Collaborations: Throughout his career, Walid M Heneine has collaborated with top researchers, medical professionals, and industry experts to bring his inventions to life. His collaborative approach has led to the successful development and commercialization of several groundbreaking medical devices.

Conclusion: Walid M Heneine's passion for innovation and dedication to improving patient care have solidified his reputation as a pioneering inventor in the medical technology sector. His contributions continue to have a lasting impact on the healthcare industry, making him a true visionary in his field.